Medtronic Diabetes receives FDA warning letter
- Wednesday, December 15, 2021, 7:11
- Business
- Add a comment
DUBLIN, Dec. 15, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced it received a warning letter from the U.S. Food and Drug Administration (FDA) on December 9 for the company’s Northridge, California, facility, the headquarters for its Diabetes Business. The warning letter was…
About the Author
adminasapcorp has written 42014 stories on this site.